Skip to main content

Davis-based Expanesthetics raises another $1.16 million in venture capital

The company is developing alternatives to general anesthetics, using technology developed through programs associated with the University of California.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.